Page 77 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 77

Page 5 of 5  Opinion Paper


              12. Nyakato P, Boulle A, Wood R, et al. Outcomes of children and adolescents living   23. Kouamou VM, Manasa J, McGregor A, et al. Dolutegravir containing regimens may
                with HIV considered lost to follow up at IeDEA-SA cohorts in the Western Cape:   need optimization for African youth failing ART [homepage on the Internet]. Oral
                Linkage to Western Cape Provincial Health Data Centre records [homepage on the   Abtract Presentation No. WEAB0203. 10th International AIDS Society Conference
                Internet].  Oral  Abstract  Presentation  No.  28.  10th  International  AIDS  Society   on HIV Science; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: https://
                Conference on HIV Science; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available   onlinelibrary.wiley.com/doi/10.1002/jia2.25327.
                from:  http://regist2.virology-education.com/presentations/2019/HIVPed/28a_
                Nyakato.pdf.                                        24. Tsondai PR, Braithwaite K, Fattii G. Describing the characteristics and long-term
                                                                      outcomes  of  adolescents  living  with  perinatally  acquired  HIV  in  the  IeDEA-
              13. Mofensen L, Vannappagari V, Scheuerle AE, et al. Periconceptional antiretroviral   Southern Africa collaboration: 2004 to 2017 [homepage on the Internet]. Oral
                exposure and central nervous system (CNS) and neural tube birth defects – Data   Abtract Presentation No. WEAB0201. 10th International AIDS Society Conference
                from Antiretroviral Pregnancy Registry (APR) [homepage on the Internet]. Oral   on HIV Science; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: https://
                Abstract Presentation No. 12. 10th International AIDS Society Conference on HIV   onlinelibrary.wiley.com/doi/10.1002/jia2.25327.
                Science; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: http://regist2.
                virology-education.com/presentations/2019/HIVPed/12a_Mofenson.pdf.  25. Joint United Nations Programme on HIV/AIDS. 2019 UNAIDS estimates [homepage
                                                                      on the Internet]. [cited n.d.]. Available from: http://aidsinfo.unaids.org.
              14. Nyemba DC, Kalk E, Hlengiwe M, et al. Lower birth weight-for-age and length-for-
                age Z-scores in infants with in utero HIV and ARV exposure: A prospective study in   26.  Gray C. The impact of maternal HIV infection on placental and neonatal immunology
                Cape Town, South Africa [homepage on the Internet]. Oral Abstract Presentation   among  children  HIV  exposed  uninfected  [homepage  on  the  Internet].  Oral
                No.  15.  10th  International  AIDS  Society  Conference  on  HIV  Science;  2019  Jul    Presentation.  5th  Workshop  on  Children  and  Adolescents  HIV  Exposed  and
                21–24; Mexico City. [cited n.d.]. Available from: http://regist2.virology-education.  Uninfected; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: https://www.
                com/presentations/2019/HIVPed/15a_Chiwoniso.pdf.      iasociety.org/HIV-Programmes/Programmes/Paediatrics-CIPHER/5th-HIV-Exposed-
                                                                      Uninfected-Child-and-Adolescent-Workshop.
              15. Zash R, Holmes L, Diseko M, et al. Neural tube defects by antiretroviral and HIV
                exposure  in  the  Tsepamo  Study,  Botswana  [homepage  on  the  Internet].  Oral   27.  Serghides L. ARV exposure and placental morphology/function [homepage on the
                Abtract  Presentation  No.  MOAX0105LB.  10th  International  AIDS  Society   Internet]. Oral Presentation. 5th Workshop on Children and Adolescents HIV Exposed
                Conference on HIV Science; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available   and Uninfected; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: https://
                from: http://programme.ias2019.org/Abstract/Abstract/4822.  www.iasociety.org/HIV-Programmes/Programmes/Paediatrics-CIPHER/ 5th-HIV-
              16. Raesima  MM,  Forhan  S,  Thomas  V,  et  al.  Addressing  the  safety  signal  with   Exposed-Uninfected-Child-and-Adolescent-Workshop.
                dolutegravir  use  at  conception:  Additional  surveillance  data  from  Botswana   28. Marchant A. Maternal determinants of immunity in children HIV exposed and
                [homepage  on  the  Internet].  Oral  Abtract  Presentation  No.  MOAX0106LB.   uninfected  [homepage  on  the  Internet].  Oral  Presentation.  5th  Workshop  on
                10th  International  AIDS  Society  Conference  on  HIV  Science;  2019  Jul  21–24;   Children and Adolescents HIV Exposed and Uninfected; 2019 Jul 21–24; Mexico
                Mexico City. [cited n.d.]. Available from: http://programme.ias2019.org/Abstract/  City.  [cited  n.d.].  Available  from:  https://www.iasociety.org/HIV-Programmes/
                Abstract/5089.                                        Programmes/Paediatrics-CIPHER/5th-HIV-Exposed-Uninfected-Child-and-
              17. Pereira G, Kim A, Jalil E, et al. No occurrences of neural tube defects among 382   Adolescent-Workshop.
                women  on  dolutegravir  at  pregnancy  conception  in  Brazil  [homepage  on  the   29. Evans C. Child mortality growth and early childhood development – Comparing
                Internet]. Oral Abtract Presentation No. MOAX0104LB. 10th International AIDS   children who are HIV exposed and uninfected and children HIV unexposed in the
                Society  Conference  on  HIV  Science;  2019  Jul  21–24;  Mexico  City.  [cited  n.d.].   SHINE  trial  [homepage  on  the  Internet].  Oral  Presentation.  5th  Workshop  on
                Available from: http://programme.ias2019.org/Abstract/Abstract/4991.  Children and Adolescents HIV Exposed and Uninfected; 2019 Jul 21–24; Mexico
              18. World Health Organisation. Update of recommendations on first- and second-line   City.  [cited  n.d.].  Available  from:  https://www.iasociety.org/HIV-Programmes/
                                                                      Programmes/Paediatrics-CIPHER/5th-HIV-Exposed-Uninfected-Child-and-
                antiretroviral regimens – Policy brief [homepage on the Internet]. [cited n.d.].   Adolescent-Workshop.
                Available from: https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en/.
              19. Venter  WF,  Moorhouse  M,  Sokhela  S,  et  al.  The  ADVANCE  trial:  Phase  3,   30. Prendergast  A.  Infant  feeding  and  WASH  interventions  among  children  HIV
                                                                      exposed  uninfected  in  SHINE  [homepage  on  the  Internet].  Oral  Presentation.
                randomized comparison of TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV for first-  5th Workshop on Children and Adolescents HIV Exposed and Uninfected; 2019 Jul
                line  treatment  of  HIV-1  infection  [homepage  on  the  Internet].  Oral  Abtract   21–24; Mexico City. [cited n.d.]. Available from: https://www.iasociety.org/HIV-
                Presentation No. WEAB0405LB. 10th International AIDS Society Conference on
                HIV Science; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: https://  Programmes/Programmes/Paediatrics-CIPHER/5th-HIV-Exposed-Uninfected-
                onlinelibrary.wiley.com/doi/10.1002/jia2.25327.       Child-and-Adolescent-Workshop.
              20.  Hill A, Venter WF, Delaporte E, et al. Progressive rises in weight and clinical obesity   31. Mulenga P, Mutanga J. Follow-up of children HIV exposed uninfected through
                for TAF/FTC/DTG and TDF/FTC/DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL   routine child health services: Zambian perspective [homepage on the Internet].
                trials.  Oral  Abtract  Presentation  No.  MOAX0102LB  [homepage  on  the  Internet].   Oral Presentation. 5th Workshop on Children and Adolescents HIV Exposed and
                10th International AIDS Society Conference on HIV Science; 2019 Jul 21–24; Mexico   Uninfected; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from: https://
                City.  [cited  n.d.].  Available  from:  https://onlinelibrary.wiley.com/doi/ 10.1002/  www.iasociety.org/HIV-Programmes/Programmes/Paediatrics-CIPHER/5th-
                jia2.25327.                                           HIV-Exposed-Uninfected-Child-and-Adolescent-Workshop.
              21. Moyo F, Haeri Mazanderani A, Murray T, et al. Characterizing viral load burden   32. Bamford L, Feucht U. Providing care for children HIV exposed uninfected through
                among HIV positive women around time of delivery: Findings from four tertiary   routine  child  health  services:  South  African  perspective  [homepage  on  the
                obstetric units in Gauteng, South Africa [homepage on the Internet]. Oral Abtract   Internet].  Oral  Presentation.  5th  Workshop  on  Children  and  Adolescents  HIV
                Presentation No. TUAB0104. 10th International AIDS Society Conference on HIV   Exposed and Uninfected; 2019 Jul 21–24; Mexico City. [cited n.d.]. Available from:
                Science;  2019  Jul  21–24;  Mexico  City.  [cited  n.d.].  Available  from:  https://  https://www.iasociety.org/HIV-Programmes/Programmes/ Paediatrics-
                onlinelibrary.wiley.com/doi/10.1002/jia2.25327.       CIPHER/5th-HIV-Exposed-Uninfected-Child-and-Adolescent- Workshop.
              22. Waalewijn  H,  Bollen  PDJ,  Moore  C.  Pharmacokinetics  of  dolutegravir  5  mg   33. Penazzato M. Integrating children HIV exposed and uninfected into the nurturing
                dispersible tablets in children weighing 6 to < 20 kg dosed using WHO weight   care framework [homepage on the Internet]. Oral Presentation. 5th Workshop on
                bands [homepage on the Internet]. Oral Abtract Presentation No. WEAB0401LB.   Children and Adolescents HIV Exposed and Uninfected; 2019 Jul 21–24; Mexico
                10th  International  AIDS  Society  Conference  on  HIV  Science;  2019  Jul  21–24;   City.  [cited  n.d.].  Available  from:  https://www.iasociety.org/HIV-Programmes/
                Mexico  City.  [cited  n.d.].  Available  from:  https://onlinelibrary.wiley.com/doi/   Programmes/Paediatrics-CIPHER/5th-HIV-Exposed-Uninfected-Child-and-
                10.1002/jia2.25327.                                   Adolescent-Workshop.






















                                           http://www.sajhivmed.org.za  70  Open Access
   72   73   74   75   76   77   78   79   80   81   82